Case
SMILE monovision
An effective and safe treatment for presbyopic ametropic patients
9 September 2019
· 2 min read
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/125-smilemonovision/image/zeiss_jakob-siedlecki.jpg/_jcr_content/renditions/original.image_file.100.100.0,12,203,215.file/zeiss_jakob-siedlecki.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/125-smilemonovision/image/zeiss_jakob-siedlecki.jpg/_jcr_content/renditions/original.image_file.203.203.0,12,203,215.file/zeiss_jakob-siedlecki.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/125-smilemonovision/image/zeiss_jakob-siedlecki.jpg/_jcr_content/renditions/original.image_file.203.203.0,12,203,215.file/zeiss_jakob-siedlecki.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/125-smilemonovision/image/zeiss_jakob-siedlecki.jpg/_jcr_content/renditions/original.image_file.203.203.0,12,203,215.file/zeiss_jakob-siedlecki.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/125-smilemonovision/image/zeiss_jakob-siedlecki.jpg/_jcr_content/renditions/original.image_file.203.203.0,12,203,215.file/zeiss_jakob-siedlecki.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/125-smilemonovision/image/zeiss_jakob-siedlecki.jpg/_jcr_content/renditions/original.image_file.203.203.0,12,203,215.file/zeiss_jakob-siedlecki.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/refractive-surgery/125-smilemonovision/image/zeiss_jakob-siedlecki.jpg/_jcr_content/renditions/original.image_file.203.203.0,12,203,215.file/zeiss_jakob-siedlecki.jpg"})
Author
Jakob Siedlecki, MD
Resident in Ophthalmology, Ludwig-Maximilians-University of Munich Munich, Germany
SUMMARY
SMILE monovision case study
The case presents SMILE as a good treatment option for a presbyopic ametropic patient with a desire for spectacle independence for computer work and hobbies like water sports.
The case confirms SMILE:
- To be an effective and safe treatment
- To be a good corneal refractive surgery mini-monovision alternative
- To be a solution for presbyopic ametropic patients with clear crystalline lens
- To provide spectacle independence for most daily activities.